Inhibrxinc Stock Fundamentals
| INBX Stock | USD 34.13 0.03 0.09% |
InhibrxInc fundamentals help investors to digest information that contributes to InhibrxInc's financial success or failures. It also enables traders to predict the movement of InhibrxInc Stock. The fundamental analysis module provides a way to measure InhibrxInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InhibrxInc stock.
At this time, InhibrxInc's Interest Expense is fairly stable compared to the past year. Selling General Administrative is likely to rise to about 30.9 M in 2024, despite the fact that Net Loss is likely to grow to (124.2 M). InhibrxInc | Select Account or Indicator |
InhibrxInc Company Operating Margin Analysis
InhibrxInc's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current InhibrxInc Operating Margin | (54.03) % |
Most of InhibrxInc's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InhibrxInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
InhibrxInc Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, InhibrxInc has an Operating Margin of -54.0324%. This is 54.03% higher than that of the Biotechnology sector and 51.79% lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
InhibrxInc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining InhibrxInc's current stock value. Our valuation model uses many indicators to compare InhibrxInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InhibrxInc competition to find correlations between indicators driving InhibrxInc's intrinsic value. More Info.InhibrxInc is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . At this time, InhibrxInc's Return On Equity is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value InhibrxInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for InhibrxInc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the InhibrxInc's earnings, one of the primary drivers of an investment's value.InhibrxInc Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InhibrxInc's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InhibrxInc could also be used in its relative valuation, which is a method of valuing InhibrxInc by comparing valuation metrics of similar companies.InhibrxInc is currently under evaluation in operating margin category among related companies.
InhibrxInc Fundamentals
| Return On Equity | -4.75 | ||||
| Return On Asset | -0.46 | ||||
| Operating Margin | (54.03) % | ||||
| Current Valuation | 1.55 B | ||||
| Shares Outstanding | 47.39 M | ||||
| Shares Owned By Insiders | 19.57 % | ||||
| Shares Owned By Institutions | 86.55 % | ||||
| Number Of Shares Shorted | 2.15 M | ||||
| Price To Book | 38.11 X | ||||
| Price To Sales | 920.99 X | ||||
| Revenue | 1.8 M | ||||
| Gross Profit | (107.99 M) | ||||
| EBITDA | (218.03 M) | ||||
| Net Income | (241.36 M) | ||||
| Cash And Equivalents | 176.38 M | ||||
| Cash Per Share | 4.52 X | ||||
| Total Debt | 210.14 M | ||||
| Debt To Equity | 4.22 % | ||||
| Current Ratio | 7.51 X | ||||
| Book Value Per Share | 0.92 X | ||||
| Cash Flow From Operations | (193.31 M) | ||||
| Short Ratio | 3.41 X | ||||
| Earnings Per Share | (5.12) X | ||||
| Target Price | 35.5 | ||||
| Number Of Employees | 166 | ||||
| Beta | 2.92 | ||||
| Market Capitalization | 1.62 B | ||||
| Total Asset | 307.89 M | ||||
| Retained Earnings | (613.73 M) | ||||
| Working Capital | 239.05 M | ||||
| Net Asset | 307.89 M |
About InhibrxInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InhibrxInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InhibrxInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InhibrxInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 149.4 K | 141.9 K | |
| Total Revenue | 1.8 M | 1.7 M | |
| Cost Of Revenue | 1.2 M | 1.1 M | |
| Stock Based Compensation To Revenue | 13.80 | 14.49 | |
| Sales General And Administrative To Revenue | 16.32 | 17.14 | |
| Research And Ddevelopement To Revenue | 105.92 | 111.21 | |
| Capex To Revenue | (2.55) | (2.42) | |
| Revenue Per Share | 0.04 | 0.04 | |
| Ebit Per Revenue | (121.79) | (115.70) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InhibrxInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InhibrxInc's short interest history, or implied volatility extrapolated from InhibrxInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out InhibrxInc Piotroski F Score and InhibrxInc Altman Z Score analysis. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.